Literature DB >> 10364349

Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.

L K Hanson1, J S Slater, Z Karabekian, H W Virgin, C A Biron, M C Ruzek, N van Rooijen, R P Ciavarra, R M Stenberg, A E Campbell.   

Abstract

Blood monocytes or tissue macrophages play a pivotal role in the pathogenesis of murine cytomegalovirus (MCMV) infection, providing functions beneficial to both the virus and the host. In vitro and in vivo studies have indicated that differentiated macrophages support MCMV replication, are target cells for MCMV infection within tissues, and harbor latent MCMV DNA. However, this cell type presumably initiates early, antiviral immune responses as well. In addressing this paradoxical role of macrophages, we provide evidence that the proficiency of MCMV replication in macrophages positively correlates with virulence in vivo. An MCMV mutant from which the open reading frames M139, M140, and M141 had been deleted (RV10) was defective in its ability to replicate in macrophages in vitro and was highly attenuated for growth in vivo. However, depletion of splenic macrophages significantly enhanced, rather than deterred, replication of both wild-type (WT) virus and RV10 in the spleen. The ability of RV10 to replicate in intact or macrophage-depleted spleens was independent of cytokine production, as this mutant virus was a poor inducer of cytokines compared to WT virus in both intact organs and macrophage-depleted organs. Macrophages were, however, a major contributor to the production of tumor necrosis factor alpha and gamma interferon in response to WT virus infection. Thus, the data indicate that tissue macrophages serve a net protective role and may function as "filters" in protecting other highly permissive cell types from MCMV infection. The magnitude of virus replication in tissue macrophages may dictate the amount of virus accessible to the other cells. Concomitantly, infection of this cell type initiates the production of antiviral immune responses to guarantee efficient clearance of acute MCMV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364349      PMCID: PMC112658     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma.

Authors:  H P Steffens; J Podlech; S Kurz; P Angele; D Dreis; M J Reddehase
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  The role of Kupffer cells in the differentiation process of hepatic natural killer cells.

Authors:  K Vanderkerken; L Bouwens; N Van Rooijen; K Van den Berg; M Baekeland; E Wisse
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

3.  Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.

Authors:  G Gribaudo; S Ravaglia; M Gaboli; M Gariglio; R Cavallo; S Landolfo
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

Review 4.  Macrophage activation and innate resistance to infection in SCID mice.

Authors:  G J Bancroft; J P Kelly
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

5.  Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.

Authors:  J L Pollock; H W Virgin
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Tissue macrophages are infected by human cytomegalovirus in vivo.

Authors:  C Sinzger; B Plachter; A Grefte; T H The; G Jahn
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

7.  Analysis of the role of CD4+ T-cells during murine cytomegalovirus infection in different strains of mice.

Authors:  X He; H Yoshida; Y Minamishima; K Nomoto
Journal:  Virus Res       Date:  1995-05       Impact factor: 3.303

8.  Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages.

Authors:  K N Fish; A S Depto; A V Moses; W Britt; J A Nelson
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes.

Authors:  M T Heise; M Connick; H W Virgin
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

10.  Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.

Authors:  J S Orange; B Wang; C Terhorst; C A Biron
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  42 in total

1.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Susan Fisher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.

Authors:  Sofia A Oliveira; Se-Ho Park; Peter Lee; Albert Bendelac; Thomas E Shenk
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Roles of macrophages in measles virus infection of genetically modified mice.

Authors:  B Roscic-Mrkic; R A Schwendener; B Odermatt; A Zuniga; J Pavlovic; M A Billeter; R Cattaneo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA.

Authors:  S A Oliveira; T E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.

Authors:  Diane M LoPiccolo; Marielle C Gold; Daniel G Kavanagh; Markus Wagner; Ulrich H Koszinowski; Ann B Hill
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen.

Authors:  L K Hanson; J S Slater; Z Karabekian; G Ciocco-Schmitt; A E Campbell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.

Authors:  Satoshi Noda; Shirley A Aguirre; Andrew Bitmansour; Janice M Brown; Timothy E Sparer; Jing Huang; Edward S Mocarski
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

Review 9.  Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus.

Authors:  Christine A Biron; Margarite L Tarrio
Journal:  Med Microbiol Immunol       Date:  2015-04-08       Impact factor: 3.402

10.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.